Janssen’s new prescription pain treatment to be available in March

Published: 2009-02-26 06:57:00

Updated: 2009-02-26 06:57:00

Janssen Korea says Jurnista prolonged-release tablets (hydromorphone HCl), a new prescription treatment for severe pain, will be available here in March, under health insurance coverage.

Jurnista was developed by Alza Corporation and utilizes the OROS (Oral Osmotic System) Push-Pull delivery s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK